SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 100 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,000 | -66.7% | 67 | -82.4% | 0.00% | – |
Q4 2019 | $3,000 | -40.0% | 380 | -39.5% | 0.00% | – |
Q3 2019 | $5,000 | -16.7% | 628 | -10.0% | 0.00% | – |
Q2 2019 | $6,000 | +100.0% | 698 | +21.8% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 573 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -25.0% | 573 | +22.4% | 0.00% | – |
Q3 2018 | $4,000 | +100.0% | 468 | +106.2% | 0.00% | – |
Q2 2018 | $2,000 | -71.4% | 227 | -53.2% | 0.00% | – |
Q1 2018 | $7,000 | – | 485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |